INT89445
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
The tumor cells were positive for human melanosome-associated protein (HMB-45) on immunohistochemical staining. | |||||||||||||||
| |||||||||||||||
|
Muscle markers (desmin and smooth muscle actin) were positive diffusely and strongly in the spindle cells of all tumors, whereas HMB-45 and CD34 were absent. | |||||||||||||||
| |||||||||||||||
|
The morules showed positive thyroid transcription factor-1 staining, weak keratin staining, and negative staining for smooth muscle actin, desmin, and HMB-45. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemically, the tumor cells are usually positive for S-100 protein, HMB-45 and vimentin and/or microphthalmia transcription factor [14]. | |||||||||||||||
| |||||||||||||||
|
There have been reports on S-100 positivity and HMB-45 negativity of this tumor type, but to the best of our knowledge, this is the first description of an EMPNST positive for MBP, chromogranin A, and synaptophisin. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemically, the tumor cells proved positive for S-100, NSE, GFAP, MBP, chromogranin A and synaptophysin, and negative for CEA, keratin, HMB-45, G-CSF, and GM-CSF. | |||||||||||||||
| |||||||||||||||
|
Estrogen receptor (ER), Progesterone receptor (PR) and HMB 45 (Human melanoma antibody) were negative. | |||||||||||||||
| |||||||||||||||
|
The immunohistochemical stains for melanoma (S100, tyrosinase, Melan A and HMB-45), carcinoma (CK), gastrointestinal stromal tumours (CD-34, vimentin and c-Kit) and lymphoma (LCA) were performed with negative results, except for a weak and focal expression of vimentin. | |||||||||||||||
| |||||||||||||||
|
The spindle cells were diffuse positive for VIM, ACT, CD68 and negative for desmin, MNF116, SyN, S100, HMB45, and CD117. | |||||||||||||||
| |||||||||||||||
|
Fragments of the tumor were fixed in 10% formaldehyde, included in paraffin, and the sections were stained with HE, VG and immunohistochemically with vimentin (VIM), MNF116, SyN, smooth muscle actin (ACT), desmin, CD68, S100, HMB45, and CD117. | |||||||||||||||
| |||||||||||||||
|
The positive expression of the HMB-45 and S-100 protein antibodies set the diagnosis of the malignant neoplasm of melanocytic origin (malignant melanoma) as the most prevalent. | |||||||||||||||
| |||||||||||||||
|
Immunoperoxidase testing was positive for CD10 and vimentin and negative for gross cystic disease fluid protein (GCDFP), S-100, HMB-45, muscle-specific antigen, and desmin, supporting the diagnosis of metastatic RCC (Figure 3). | |||||||||||||||
| |||||||||||||||
|
Melan A and HMB45 were negative excluding a melanocytic lesion or an angiomyolipoma. | |||||||||||||||
| |||||||||||||||
|
The tumour cells expressed S-100 protein and glial fibrillary acidic protein (GFAP) and were negative for HMB45, melan A, smooth muscle actin (SMA), desmin, CD34 and CD117. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemical staining showed that the cells expressed neuroendocrine markers (synaptophysin, chromogranin, NSE) and cytokeratin marker (CAM 5.2) but were negative for S100, HMB45, CD99 and CD117. | |||||||||||||||
| |||||||||||||||
|
These were negative for cytokeratin (AE1/AE3), HMB45, S100 protein, melanin A, NSE (neuron specific enolase), CD34 and CD 117. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemistry showed strong and diffuse positive staining for neuroendocrine markers (NSE, chromogranin, synaptophysin) and CAM 5.2 but was negative for EMA, S100 and HMB45. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.